NFSG
CLVS

Newbridge Financial Services Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Newbridge Financial Services Group’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,500
Closed -$659 – 1503
2022
Q4 		$659 Hold
12,500
– – ﹤0.01% 1344
2022
Q3 		$15K Sell
12,500
-653
-5% -$1.02K 0.01% 789
2022
Q2 		$24K Buy
13,153
+6,500
+98% +$9.59K 0.01% 612
2022
Q1 		$13K Hold
6,653
– – 0.01% 873
2021
Q4 		$18K Hold
6,653
– – 0.01% 769
2021
Q3 		$30K Buy
6,653
+3,500
+111% +$16.9K 0.02% 558
2021
Q2 		$18K Hold
3,153
– – 0.01% 815
2021
Q1 		$22K Buy
3,153
+1,653
+110% +$11.1K 0.02% 674
2020
Q4 		$7K Hold
1,500
– – 0.01% 804
2020
Q3 		$9K Buy
+1,500
New +$8.97K 0.01% 711

Other funds holding CLVS

RMC
Resources Management Corp West Hartford, Connecticut $794M AUM 25.46% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

Newbridge Financial Services Group's CLVS Position: Q1 2023 in Review

Newbridge Financial Services Group sold out of Clovis Oncology, Inc. (CLVS) in Q1 2023, closing a stake of 12,500 shares — an estimated $659 sold.

Newbridge Financial Services Group first reported a position in CLVS in Q3 2020 and held it in 10 quarters. The position peaked at $30K in Q3 2021. 2 funds tracked by Wall St. Rank hold CLVS as of Q1 2023.

  • Newbridge Financial Services Group reported no remaining Clovis Oncology, Inc. position as of Q1 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 12,500 Clovis Oncology, Inc. shares in Q1 2023, an estimated $659.
  • Newbridge Financial Services Group first reported a position in Clovis Oncology, Inc. in Q3 2020 and held it in 10 quarters.
  • Newbridge Financial Services Group's Clovis Oncology, Inc. position peaked at $30K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2023.

Based on Newbridge Financial Services Group's 13F filing for Q1 2023, filed 18 Apr 2023.